R. E. Çeçen Et Al. , "THE RESPONSE OF LORLATINIB TREATMENT COMBINED WITH CHEMOTHERAPY AND CRANIOSPINAL RADIOTHERAPY ON CENTRAL NERVOUS SYSTEM RELAPSE OF HIGH-RISK NEUROBLASTOMA WITH ALKF1174 L MUTATION," The 54th Annual Congress of the International Society of Paediatric Oncology , Barcelona, Spain, pp.1821, 2022
Çeçen, R. E. Et Al. 2022. THE RESPONSE OF LORLATINIB TREATMENT COMBINED WITH CHEMOTHERAPY AND CRANIOSPINAL RADIOTHERAPY ON CENTRAL NERVOUS SYSTEM RELAPSE OF HIGH-RISK NEUROBLASTOMA WITH ALKF1174 L MUTATION. The 54th Annual Congress of the International Society of Paediatric Oncology , (Barcelona, Spain), 1821.
Çeçen, R. E., İnce, D., Aktaş, S., Kızmazoğlu, D., Güleryüz Uçar, H., Aktaş, T., ... Kızmazoğlu, C.(2022). THE RESPONSE OF LORLATINIB TREATMENT COMBINED WITH CHEMOTHERAPY AND CRANIOSPINAL RADIOTHERAPY ON CENTRAL NERVOUS SYSTEM RELAPSE OF HIGH-RISK NEUROBLASTOMA WITH ALKF1174 L MUTATION . The 54th Annual Congress of the International Society of Paediatric Oncology (pp.1821). Barcelona, Spain
Çeçen, REFİK Et Al. "THE RESPONSE OF LORLATINIB TREATMENT COMBINED WITH CHEMOTHERAPY AND CRANIOSPINAL RADIOTHERAPY ON CENTRAL NERVOUS SYSTEM RELAPSE OF HIGH-RISK NEUROBLASTOMA WITH ALKF1174 L MUTATION," The 54th Annual Congress of the International Society of Paediatric Oncology, Barcelona, Spain, 2022
Çeçen, REFİK E. Et Al. "THE RESPONSE OF LORLATINIB TREATMENT COMBINED WITH CHEMOTHERAPY AND CRANIOSPINAL RADIOTHERAPY ON CENTRAL NERVOUS SYSTEM RELAPSE OF HIGH-RISK NEUROBLASTOMA WITH ALKF1174 L MUTATION." The 54th Annual Congress of the International Society of Paediatric Oncology , Barcelona, Spain, pp.1821, 2022
Çeçen, R. E. Et Al. (2022) . "THE RESPONSE OF LORLATINIB TREATMENT COMBINED WITH CHEMOTHERAPY AND CRANIOSPINAL RADIOTHERAPY ON CENTRAL NERVOUS SYSTEM RELAPSE OF HIGH-RISK NEUROBLASTOMA WITH ALKF1174 L MUTATION." The 54th Annual Congress of the International Society of Paediatric Oncology , Barcelona, Spain, p.1821.
@conferencepaper{conferencepaper, author={REFİK EMRE ÇEÇEN Et Al. }, title={THE RESPONSE OF LORLATINIB TREATMENT COMBINED WITH CHEMOTHERAPY AND CRANIOSPINAL RADIOTHERAPY ON CENTRAL NERVOUS SYSTEM RELAPSE OF HIGH-RISK NEUROBLASTOMA WITH ALKF1174 L MUTATION}, congress name={The 54th Annual Congress of the International Society of Paediatric Oncology}, city={Barcelona}, country={Spain}, year={2022}, pages={1821} }